These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 20924210)

  • 1. Effects of the knockdown of hypoxia inducible factor-1α expression by adenovirus-mediated shRNA on angiogenesis and tumor growth in hepatocellular carcinoma cell lines.
    Choi SH; Shin HW; Park JY; Yoo JY; Kim DY; Ro WS; Yun CO; Han KH
    Korean J Hepatol; 2010 Sep; 16(3):280-7. PubMed ID: 20924210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of tumour angiogenesis and growth by small hairpin HIF-1α and IL-8 in hepatocellular carcinoma.
    Choi SH; Kwon OJ; Park JY; Kim DY; Ahn SH; Kim SU; Ro SW; Kim KS; Park JH; Kim S; Yun CO; Han KH
    Liver Int; 2014 Apr; 34(4):632-42. PubMed ID: 24321089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of HIF-1α and IL-8 induced apoptosis of hepatocellular carcinoma triggers apoptosis of vascular endothelial cells.
    Choi SH; Park JY; Kang W; Kim SU; Kim do Y; Ahn SH; Ro SW; Han KH
    Apoptosis; 2016 Jan; 21(1):85-95. PubMed ID: 26467924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNAi Knockdown of Hypoxia-Inducible Factor-1α Decreased the Proliferation, Migration, and Invasion of Hypoxic Hepatocellular Carcinoma Cells.
    Chen C; Liu R; Wang J; Yan Z; Qian S; Zhang W
    Cell Biochem Biophys; 2015 Apr; 71(3):1677-84. PubMed ID: 25388848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-inducible factor 1, hepatocellular carcinoma and angiogenesis.
    Kim JW
    Korean J Hepatol; 2010 Sep; 16(3):278-9. PubMed ID: 20924209
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclin-dependent kinase 5 stabilizes hypoxia-inducible factor-1α: a novel approach for inhibiting angiogenesis in hepatocellular carcinoma.
    Herzog J; Ehrlich SM; Pfitzer L; Liebl J; Fröhlich T; Arnold GJ; Mikulits W; Haider C; Vollmar AM; Zahler S
    Oncotarget; 2016 May; 7(19):27108-21. PubMed ID: 27027353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bclaf1 promotes angiogenesis by regulating HIF-1α transcription in hepatocellular carcinoma.
    Wen Y; Zhou X; Lu M; He M; Tian Y; Liu L; Wang M; Tan W; Deng Y; Yang X; Mayer MP; Zou F; Chen X
    Oncogene; 2019 Mar; 38(11):1845-1859. PubMed ID: 30367150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMP9-ID1 Signaling Activates HIF-1α and VEGFA Expression to Promote Tumor Angiogenesis in Hepatocellular Carcinoma.
    Chen H; Nio K; Tang H; Yamashita T; Okada H; Li Y; Doan PTB; Li R; Lv J; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo.
    Moser C; Lang SA; Mori A; Hellerbrand C; Schlitt HJ; Geissler EK; Fogler WE; Stoeltzing O
    BMC Cancer; 2008 Jul; 8():206. PubMed ID: 18651980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. γ-H2AX promotes hepatocellular carcinoma angiogenesis via EGFR/HIF-1α/VEGF pathways under hypoxic condition.
    Xiao H; Tong R; Ding C; Lv Z; Du C; Peng C; Cheng S; Xie H; Zhou L; Wu J; Zheng S
    Oncotarget; 2015 Feb; 6(4):2180-92. PubMed ID: 25537504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
    Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
    J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transcription factor ZFHX3 is crucial for the angiogenic function of hypoxia-inducible factor 1α in liver cancer cells.
    Fu C; An N; Liu J; A J; Zhang B; Liu M; Zhang Z; Fu L; Tian X; Wang D; Dong JT
    J Biol Chem; 2020 May; 295(20):7060-7074. PubMed ID: 32277050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin inhibits hypoxia-induced angiogenesis via down-regulation of HIF-1.
    Bae MK; Kim SH; Jeong JW; Lee YM; Kim HS; Kim SR; Yun I; Bae SK; Kim KW
    Oncol Rep; 2006 Jun; 15(6):1557-62. PubMed ID: 16685395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sorafenib inhibits hypoxia-inducible factor-1α synthesis: implications for antiangiogenic activity in hepatocellular carcinoma.
    Liu LP; Ho RL; Chen GG; Lai PB
    Clin Cancer Res; 2012 Oct; 18(20):5662-71. PubMed ID: 22929805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
    Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
    Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Histone Methyltransferase Inhibitor BIX01294 Inhibits HIF-1α Stability and Angiogenesis.
    Oh SY; Seok JY; Choi YS; Lee SH; Bae JS; Lee YM
    Mol Cells; 2015 Jun; 38(6):528-34. PubMed ID: 26013382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of hypoxia-inducible factor-1β induces anti-tumor effects in hepatoma cell lines under tumor hypoxia.
    Choi SH; Chung AR; Kang W; Park JY; Lee MS; Hwang SW; Kim DY; Kim SU; Ahn SH; Kim S; Han KH
    PLoS One; 2014; 9(7):e103304. PubMed ID: 25068796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role and mechanism of HIF-1α-mediated glypican-3 secretion in hypoxia-induced tumor progression in hepatocellular carcinoma.
    Wang P; Tong K; Li Y; Li X; Zhang Y; Gu J; Lei P; Yan S; Hu P
    Cell Signal; 2024 Feb; 114():111007. PubMed ID: 38081444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIF-1α promotes the migration and invasion of hepatocellular carcinoma cells via the IL-8-NF-κB axis.
    Feng W; Xue T; Huang S; Shi Q; Tang C; Cui G; Yang G; Gong H; Guo H
    Cell Mol Biol Lett; 2018; 23():26. PubMed ID: 29881400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The epigallocatechin gallate derivative Y
    Liao ZH; Zhu HQ; Chen YY; Chen RL; Fu LX; Li L; Zhou H; Zhou JL; Liang G
    J Ethnopharmacol; 2020 Sep; 259():112852. PubMed ID: 32278759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.